United States · Venture startup

Who invested in Cardlytics

3 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 31 Oct 2026

$143Mraised across 3 rounds since 2011, from 3 sources

$33MVenture$40MVenture$70MVenture
Latest round
Venture, $70MOct 2014
Step-upi
1.8×
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201220132014
$33MVenture$40MVenture$70MVenture
First round
Venture, $33M
Sept 2011
Biggest round
$70M
Venture · Oct 2014
Usual gap between rounds
20 months
the median of 2

The rounds

  1. Oct 2014
    Venture$70M

    No investor was named in the report.

    From a historical funding record

  2. May 2013
    Venture$40M

    No investor was named in the report.

    From a historical funding record

  3. Sept 2011
    Venture$33M

    No investor was named in the report.

    From a historical funding record

Also claim to have backed them

These 3 firms list Cardlytics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

TTV CapitalVC firmPer its own site
Next Coast VenturesVC firmPer its own site
Savano Capital PartnersVC firmPer its own site

Quick answers about Cardlytics

How much has Cardlytics raised?

Cardlytics has raised $143M across 3 rounds since 2011.

When did Cardlytics last raise?

Cardlytics's most recent round was a Venture of $70M in Oct 2014.

What was Cardlytics's biggest round?

Its most recent round, $70M in Oct 2014, is also its largest on record.

What stage is Cardlytics at?

Cardlytics's latest named round is a Venture, in Oct 2014.

Where is Cardlytics based?

Cardlytics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.